{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:09:19Z","timestamp":1762430959144},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["U54 CA13642","R01 CA142750","P30 DK34933","P50 CA93990"],"award-info":[{"award-number":["U54 CA13642","R01 CA142750","P30 DK34933","P50 CA93990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jconrel.2014.11.034","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T23:49:25Z","timestamp":1417736965000},"page":"114-121","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles"],"prefix":"10.1016","volume":"199","author":[{"given":"Supang","family":"Khondee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily F.","family":"Rabinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishnu P.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11","author":"Ferlay","key":"10.1016\/j.jconrel.2014.11.034_bb0005"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/jnci\/djh275","article-title":"Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging","volume":"96","author":"O'Connell","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clinthera.2010.03.012","article-title":"Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review","volume":"32","author":"Tol","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0030","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2011.38.6599","article-title":"Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer","volume":"30","author":"Weickhardt","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0035","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1021\/bm049305m","article-title":"Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan\u2013deoxycholic acid conjugates","volume":"6","author":"Kim","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0040","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1021\/la0350608","article-title":"Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5B-cholanic acid","volume":"19","author":"Kwon","year":"2003","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0045","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1021\/bm100989x","article-title":"Synthesis and characterization of amphiphilic glycidol\u2013chitosan\u2013deoxycholic acid nanoparticles as a drug carrier for doxorubicin","volume":"11","author":"Zhou","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1568011013354877","article-title":"Peptides as carrier for tumor diagnosis and treatment","volume":"1","author":"Langer","year":"2001","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nm1692","article-title":"Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy","volume":"14","author":"Hsiung","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0060","doi-asserted-by":"crossref","first-page":"0211031","DOI":"10.1117\/1.JBO.17.2.021103","article-title":"Targeted detection of murine colonic dysplasia in vivo with flexible multispectral scanning fiber endoscopy","volume":"17","author":"Miller","year":"2012","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0065","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1158\/0008-5472.CAN-07-2735","article-title":"Mouse model of colonic adenoma\u2013carcinoma progression based on somatic Apc inactivation","volume":"67","author":"Hinoi","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0070","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.97.7.3352","article-title":"APC mutations in sporadic colorectal tumors: a mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits\u201d","volume":"97","author":"Rowan","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3011.1990.tb00939.x","article-title":"Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids","volume":"35","author":"Fields","year":"1990","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0095","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.gie.2008.09.054","article-title":"Endoscopic imaging and size estimation of colorectal adenomas in the multiple intestinal neoplasia mouse","volume":"69","author":"Hensley","year":"2009","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0100","doi-asserted-by":"crossref","first-page":"e78086","DOI":"10.1371\/journal.pone.0078086","article-title":"Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2\/ErbB3\/AKT and MET\/ErbB3\/MAPK","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0105","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/aic.12119","article-title":"Core\/shell pH-sensitive micelles self-assembled from cholesterol conjugated oligopeptides for anticancer drug delivery","volume":"56","author":"Guo","year":"2010","journal-title":"AIChE J."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2013.07.016","article-title":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren's syndrome","volume":"171","author":"Shah","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0115","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0125","doi-asserted-by":"crossref","first-page":"13544","DOI":"10.1073\/pnas.0800041105","article-title":"Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc716 mice","volume":"105","author":"Fujishita","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0130","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/onc.2009.435","article-title":"Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin\/+ mice","volume":"29","author":"Koehl","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2014.11.034_bb0135","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1158\/1535-7163.MCT-11-0987","article-title":"Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing paclitaxel, rapamycin, and 17-AAG","volume":"11","author":"Hasenstein","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10611860600691049","article-title":"EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells","volume":"14","author":"Mamot","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/138920111796117328","article-title":"pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cells","volume":"12","author":"Garg","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0076","article-title":"Drug-associated renal dysfunction and injury","volume":"2","author":"Choudhury","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jcp.2008.058271","article-title":"Renal toxicity of therapeutic drugs","volume":"62","author":"John","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jconrel.2014.11.034_bb0160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.47102\/annals-acadmedsg.V38N3p240","article-title":"Drug-induced kidney disease-pathology and current concepts","volume":"38","author":"Loh","year":"2009","journal-title":"Ann. Acad. Med. Singap."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914007858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914007858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T13:03:26Z","timestamp":1690722206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914007858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":29,"alternative-id":["S0168365914007858"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.034","relation":{},"ISSN":["0168-3659"],"issn-type":[{"type":"print","value":"0168-3659"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}